Transcat, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRNS research report →
Range $115 – $115
Price Chart
About the company
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
- CEO
- Jaime A. Irick
- IPO
- 1977
- Employees
- 1,413
- HQ
- Rochester, NY, US
Get TickerSpark's AI analysis on TRNS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $937.19M
- P/E
- 203.37
- Fwd P/E
- 46.96
- PEG
- -3.05
- P/S
- 2.58
- P/B
- 3.03
- EV/EBITDA
- 26.53
- Div Yield
- 0.00%
- Gross Margin
- 32.79%
- Op Margin
- 3.32%
- Net Margin
- 1.26%
- ROE
- 1.52%
- ROIC
- 1.73%
Latest fiscal year · YoY change
- Revenue
- $331.88M+19.2%
- Gross Profit
- $108.30M+21.1%
- Op Income
- $13.26M
- Net Income
- $5.38M-63.0%
- EPS
- $0.58-63.3%
- OCF Growth
- -10.6%
- FCF Growth
- -24.2%
- Beta
- 0.64
- RSI (14)
- 48
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Transcat posted another strong quarter with 18% revenue growth, expanding margins, and a higher full-year service growth outlook driven by service momentum and acquisitions.· November 3, 2026
- Consolidated revenue rose 18% to $97.1 million, led by double-digit growth in both service and distribution.
- Adjusted EPS increased 46% to $0.64, while adjusted EBITDA grew 23% to $14.9 million and margin expanded to 15.4%.
- Service was the standout: revenue grew 23% to $64.8 million, organic growth accelerated to 16%, and service gross margin expanded 220 basis points to 34.4%.
- Management raised full-year fiscal 2027 service organic revenue growth guidance to low double digits from high single digits.
- Distribution grew 10% to $32.3 million, but margins were pressured by lower-margin used equipment sales; management expects improvement in the second half.
Second-quarter consolidated revenue was $97.1 million, up 18% year over year. Consolidated gross profit was $32.6 million, up 22%, and consolidated gross margin expanded 110 basis points to 33.6%. Net income grew 90%, diluted EPS increased 79% to $0.25, and adjusted diluted EPS rose 46% to $0.64. Adjusted EBITDA was $14.9 million, up 23%, with adjusted EBITDA margin up 70 basis points to 15.4%. By segment, service revenue rose 23% to $64.8 million with 16% organic growth, and service gross margin improved to 34.4%; distribution revenue rose 10% to $32.3 million and distribution gross margin was 32%. For the first six months, operating free cash flow was $10.9 million, up $3.4 million or 46%, capital expenditures were $8.1 million, total debt was $116.9 million, available borrowing was $33.1 million, and leverage was 2.18x. Management raised full-year fiscal 2027 service organic revenue growth outlook to low double digits from high single digits and reiterated full-year service gross margin expansion, including at least 100 basis points of year-over-year expansion in the second half.
Jaime Irick framed the quarter as proof that Transcat’s strategy is working across growth, margins, M&A, and rentals. He emphasized a focus on operational excellence, Lean principles, pricing, business mix, and technology including AI, saying the company is building repeatable levers to expand margins and support sustained growth. He also highlighted the 70th consecutive quarter of service revenue growth, the Southeastern Biomedical acquisition, and a long-term path to $500 million in revenue over three to five years.
Tom Barbato focused on the quarter’s financial leverage and the quality of the growth. He highlighted $97.1 million of revenue, $32.6 million of gross profit, $14.9 million of adjusted EBITDA, and $0.64 of adjusted EPS, plus operating free cash flow of $10.9 million in the first half and leverage of 2.18x at quarter end. He said distribution margins were pressured mainly by lower-margin used equipment sales tied to reinvesting in the rental asset portfolio, but he expects year-over-year distribution margin improvement in fiscal 2027, driven by the higher-margin rental channel.
Analysts focused on what drove the jump in service organic growth, with management saying the 16% growth reflected mostly market share gains, plus some pricing, in a market they believe is growing around 4% to 6%. They also asked about the service margin step-up and management said it was a mix of volume leverage, better pricing, business-mix management, and early benefits from operational initiatives. On distribution, management said rental remains healthy at low-double-digit growth, but used equipment sales can weigh on margins in the near term; they expect second-half margin expansion. Questions on larger customer wins, energy/data-center demand, and M&A drew responses that these are emerging opportunities, but the company emphasized broad-based growth rather than dependence on any single vertical.
The call showed broad-based momentum with service organic growth accelerating to 16%, 70 straight quarters of service growth, and management now seeing enough visibility to raise full-year service organic growth guidance. Margins are also trending favorably, with service gross margin up 220 basis points and management saying operational excellence and mix improvements still have a long runway.
Distribution margins are still being dragged by lower-margin used equipment sales, and management said the business will need second-half improvement to offset that. The company also acknowledged that some larger customer wins can involve upfront costs and that AI and Lean-based productivity gains will take time to fully show up, even though they are already seeing early benefits.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.5%
- Shares Outstanding
- 9.40M
- Float Shares
- 9.17M
of shares held by institutions
177 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 734.28K | ▲ 7.27K |
| Neuberger Berman Group LLC | 655.59K | ▼ 121.77K |
| Hood River Capital Management LLC | 601.54K | ▼ 13.01K |
| Vanguard Group Inc | 530.78K | ▲ 11 |
| Ophir Asset Management Pty Ltd | 462.02K | ▼ 83.50K |
| Vanguard Capital Management LLC | 396.88K | ▼ 17.18K |
| Barrow Hanley Mewhinney & Strauss LLC | 380.18K | ▼ 19.81K |
| Conestoga Capital Advisors, LLC | 344.57K | ▼ 104.98K |
| Royce & Associates LP | 340.00K | ▼ 91.68K |
| Wellington Management Group Llp | 317.01K | ▲ 19.29K |
| Dimensional Fund Advisors LP | 297.24K | ▲ 21.95K |
| Geode Capital Management, LLC | 247.64K | ▲ 4.50K |
Held by 204 ETFs
Biggest fund positions in TRNS by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 5, 26 | Conroy Theresa A. | other | 2,000 |
| Nov 5, 26 | Conroy Theresa A. | other | 1,550 |
| Nov 5, 26 | Conroy Theresa A. | other | 2,000 |
| Nov 5, 26 | Barbato Thomas L | other | 6,000 |
| Nov 5, 26 | Barbato Thomas L | other | 5,488 |
| Nov 5, 26 | Barbato Thomas L | other | 6,000 |
| Nov 5, 26 | IRICK JAIME A | buy | 2,275 |
| Sep 10, 26 | Mecca Robert | other | 1,587 |
| Sep 9, 26 | Mecca Robert | other | 1,671 |
| Sep 10, 26 | Mecca Robert | other | 1,587 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our TRNS coverage
Recent articles, reports, and earnings notes.
No research on TRNS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRNS report →